Department of Animal and Poultry Sciences, Virginia Tech, Blacksburg, VA 24061, USA.
Poult Sci. 2010 Dec;89(12):2597-607. doi: 10.3382/ps.2010-00987.
Escalating consumer concerns regarding pathogen resistance have placed the poultry industry under mounting pressure to eliminate the use of chemotherapeutic agents as feed additives. One possible alternative receiving increased attention is the use of immunomodulators such as β-glucan. A study was conducted to investigate the effects of a yeast-derived β-glucan (Auxoferm YGT) on broiler chick performance, lesion scores, and immune-related gene expression during a mixed Eimeria infection. Day-old chicks were fed diets containing 0, 0.02, or 0.1% YGT. On d 8 posthatch, one-half of the replicate pens were challenged with a mixed inoculum of Eimeria acervulina, Eimeria maxima, and Eimeria tenella. Measurements were taken and samples collected on d 4, 10, 14, and 21 posthatch. Dietary supplementation had no effect on performance or mortality. On d 14, 3 birds per pen (n = 24/treatment) were scored for intestinal coccidia lesions. Gross lesion severity was significantly reduced in birds supplemented with 0.1% YGT. On d 10, inducible nitric oxide synthase (iNOS) expression was downregulated in the jejunum of challenged birds fed 0.1% YGT. Expression of iNOS in the ileum was downregulated in the nonchallenged birds, but upregulated in the challenged birds fed 0.1% YGT on d 14. Interleukin (IL)-18 was upregulated in the jejunum of 0.1% YGT-treated birds. Interferon (IFN)-γ expression was decreased in challenged and nonchallenged birds fed 0.1% YGT. The IL-4 expression was downregulated in the nonchallenged birds with 0.1% YGT diet supplementation. The IL-13 and mucin-1 levels were also reduced due to β-glucan supplementation. Mucin-2 expression was increased in the nonchallenged birds, but decreased in the infected birds fed 0.1% YGT. These results suggest that although Auxoferm YGT at doses of 0.02 and 0.1% does not influence performance, it significantly reduces lesion severity and is capable of altering immune-related gene expression profiles, favoring an enhanced T helper type-1 cell response during coccidiosis.
消费者对病原体耐药性的担忧不断升级,这使得家禽业面临越来越大的压力,需要淘汰将化学治疗剂用作饲料添加剂。一种受到越来越多关注的可能替代品是使用免疫调节剂,如β-葡聚糖。本研究旨在调查酵母来源的β-葡聚糖(Auxoferm YGT)对肉鸡生产性能、病变评分和混合艾美耳球虫感染期间免疫相关基因表达的影响。1 日龄雏鸡饲喂含有 0、0.02 或 0.1%YGT 的日粮。在孵出后第 8 天,一半的重复鸡舍用混感艾美耳球虫(柔嫩艾美耳球虫、毒害艾美耳球虫和堆型艾美耳球虫)接种物攻毒。在孵出后第 4、10、14 和 21 天进行测量和采样。日粮添加对生产性能或死亡率没有影响。在孵出后第 14 天,每栏 3 只鸡(n=24/处理)进行肠道球虫病变评分。补充 0.1%YGT 的鸡的总病变严重程度显著降低。在攻毒鸡的空肠中,诱导型一氧化氮合酶(iNOS)的表达在第 10 天被下调。在未攻毒的鸡中,回肠中的 iNOS 表达被下调,但在攻毒且饲喂 0.1%YGT 的鸡中被上调。在饲喂 0.1%YGT 的鸡的空肠中,白细胞介素(IL)-18 上调。在饲喂 0.1%YGT 的攻毒和未攻毒鸡中,干扰素(IFN)-γ的表达下降。在未攻毒且添加 0.1%YGT 的日粮中,IL-4 的表达下调。由于β-葡聚糖的添加,IL-13 和粘蛋白-1 的水平也降低。在未攻毒的鸡中,粘蛋白-2 的表达增加,但在感染的鸡中饲喂 0.1%YGT 时则减少。这些结果表明,虽然 Auxoferm YGT 的剂量为 0.02 和 0.1%时不会影响生产性能,但它显著降低病变严重程度,并且能够改变免疫相关基因表达谱,有利于在球虫病期间增强 T 辅助细胞 1 型反应。